This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Qiagen Gmbh. Active years: 2019-2022.
Company Filing History:
Years Active: 2019-2022
Title: Katja Heitz: Innovator in RNA Sequencing and Nucleic Acid Detection
Introduction
Katja Heitz is a prominent inventor based in Hilden, Germany. She has made significant contributions to the field of molecular biology, particularly in RNA sequencing and nucleic acid detection. With a total of 2 patents, her work has advanced the understanding and application of genetic research.
Latest Patents
One of her latest patents is a method for generating an RNA-sequencing library. This invention refers to a novel method of preparing strand-specific RNA-sequencing libraries that can be used to identify DNA coding and non-coding strands that are transcribed to RNA. Such strand-specific RNA-sequencing libraries are especially useful in discovering anti-sense RNA and non-coding RNA. The method employs random primer oligonucleotides, covalently coupled to a moiety that blocks ligation, for the RT reaction or the subsequent generation of the second DNA strand. This ensures that only one strand of the generated double-stranded DNA is ligated to sequencing adapters at the 5' nucleotide and sequenced by paired-end sequencing.
Another significant patent by Katja Heitz relates to nucleic acid detection and quantification. This invention encompasses methods and uses for the detection or quantification of newly-synthesized double-stranded target nucleic acid molecules in a sample during quantitative real-time polymerase chain reaction (qPCR) amplification. The invention utilizes an intercalating dye that recognizes double-stranded DNA molecules with higher affinity than single-stranded DNA molecules, along with a fluorophore-labeled oligonucleotide-probe that is sequence-specific for a target nucleic acid molecule. This innovative approach enables the quantification of a specific target and the total amount of a mixed nucleic acid population, while also assessing the cause of suboptimal PCR performance.
Career Highlights
Katja Heitz is currently associated with Qiagen GmbH, a leading company in the field of molecular diagnostics and life sciences. Her work at Qiagen has allowed her to focus on developing cutting-edge technologies that enhance genetic research and diagnostics.
Collaborations
Throughout her career, Katja has collaborated with notable colleagues, including Nan Fang and Andreas Missel. These collaborations have contributed to her innovative research and the successful development of her patents.
Conclusion
Katja Heitz is